Bloomberg is reporting today that Takeda is now offering $2.3 billion – $100 million more than was offered on April 1, 2015 – to settle the 8,000 Actos cases currently on file in state and federal courts across the U.S. This is equal to $287,500 per case which figures to be only $12,500 more per case than their previous offer. …
ACTOS UPDATE: Takeda Offers Massive Settlement for Actos Users
Bloomberg News is reporting that Takeda Pharmaceutical Co., Asia’s largest drugmaker, is offering a $2.2 billion settlement for the 8,000 Actos lawsuits filed in state and federal courts throughout the U.S. On an individual basis, the settlement amount figures to be $275,000 per lawsuit. As the T&T blog has reported in the past, Actos sales peaked in March 2011 at …
Takeda Jury in Philadelphia Told Actos Responsible for Man’s Cancer
A Philadelphia jury was sent to deliberate Wednesday afternoon after being urged to find that Takeda Pharmaceuticals Inc. had willfully worked to obscure evidence linking the blockbuster diabetes drug Actos to an increased risk of bladder cancer. Miller Firm LLC attorney Michael Miller asked the jury during closing arguments to return a verdict in favor of plaintiff John Kristufek, who …
Actos Caused Consumer’s Bladder Cancer, Philly Jury Hears
A Philadelphia jury heard opening arguments on Wednesday in a case against Takeda Pharmaceutical Co., the latest in a string of suits against the drugmaker, alleging that a retired high-school teacher developed bladder cancer after taking the diabetes drug Actos. Miller Firm LLC attorney Michael Miller told the jury that warnings issued beginning in June 2011 about the risks associated …
Takeda Ordered to Pay for Destroying Actos Files
Bloomberg is reporting that Takeda Pharmaceutical was ordered by a jury to pay $155,000 over its destruction of documents about its Actos diabetes medicine after the panel concluded the missing files blocked a man from proving his claims that the drug caused his cancer. Jurors in state court in Martinsburg, West Virginia, deliberated about three hours today before concluding Takeda …
First Actos Bladder Cancer Suit In W.Va. Goes To Trial
The first trial in West Virginia state court over allegations that Takeda Pharmaceutical Co. Ltd.’s widely prescribed diabetes drug Actos causes bladder cancer begins today, featuring the same plaintiffs firm that has taken Actos cases to trial in four other states and secured three pro-plaintiff verdicts. The West Virginia trial comes shortly after the Miller Firm LLC secured a $2 …
Takeda, Lilly Say Prejudice Infected $9B Actos Verdict
Takeda Pharmaceutical Co. Ltd. and Eli Lilly & Co. argued Friday that the sheer size of the $9 billion punitive damages award they suffered in the bellwether personal injury trial over the diabetes drug Actos demonstrates the jury was inflamed by “passion and prejudice,” saying its verdict should be overturned. Reported as the seventh-largest punitive damages award in U.S. history, the April …
Burned in Federal Court, Takeda Hopes to Find Solace in State Courts Over Actos Drug
Word to the Wise: Plaintiffs should avoid state courts when suing Takeda over their diabetes drug Actos. Why? Because Takeda has been slammed with a $6 billion verdict and disciplined for destroying key evidence in federal court over Actos, but the drugmaker has found success in state courts by convincing juries that it adequately warned of the drug’s bladder cancer …